Abstract
The metabolic investigation of natural products is a great challenge because of unpredictable metabolic pathways, little knowledge on metabolic effects, and lack of recommended analytical methodology. Herein, a combined strategy based on ultrahigh-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (UHPLC/Q-TOF-MS), nuclear magnetic resonance (NMR) spectroscopy, and electronic circular dichroism (ECD) calculation was developed and employed for the human metabolism study of gentiopicroside (GPS), a naturally hepato-protective iridoid glycoside. The whole metabolic study consisted of three major procedures. First, an improved UHPLC/Q-TOF-MS method was used to separate and detect a total of 15 GPS metabolites that were obtained from urine samples (0 to 72 h) of 12 healthy male participants after a single 50-mg oral dose of GPS. Second, a developed “MS-NMR-MS” method was applied to accurately identify molecular structures of the observed metabolites. Finally, given that the associated stereochemistry may be a crucial factor of the metabolic activation, the absolute configuration of the reactive metabolites was revealed through chemical calculations. Based on the combined use, a pair of diastereoisomers (G05 and G06) were experimentally addressed as the bioreactive metabolites of GPS, and the stereochemical determination was completed. Whereas several novel metabolic transformations, occurring via oxidation, N-heterocyclization and glucuronidation after deglycosylation, were also observed. The results indicated that GPS has to undergo in vivo metabolism-based activation to generate reactive molecules capable of processing its hepato-protective activity.
Similar content being viewed by others
References
White NJ (2008) Science 320:330–334
Newman DJ, Cragg GM (2012) J Nat Prod 75:311–335
Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ (2010) N Engl J Med 362:1663–1674
Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB (2006) Diabetes 55:2256–2264
Gao CY, Chen XY, Zhong DF (2011) Drug Metab Dispos 39:2034–2044
Zhou SF, Xue CC, Yu XQ, Wang G (2007) Curr Drug Metab 8:526–553
Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, Ikegami T, Tanaka N, Akita H, Ito K, Suzuki H, Sugiyama Y (2004) Hepatology 39:167–178
Tony P, Martin B (2002) Drug Discov Today 7:554
Tang W, Lu AY (2009) Curr Pharm Des 15:2170–2183
Zhang D, Zhu M, Humphreys WG (2008) Drug Metabolism in Drug Design and Development. John Wiley & Sons, Hoboken
Anders MW (1971) Annu Rev Pharmacol 11:37–56
Meermann B, Hulstaert A, Laenen A, Van Looveren C, Vliegen M, Cuyckens F, Vanhaecke F (2012) Anal Chem 84:2395–2401
Horstkötter C, Schepmann D, Blaschke G (2003) J Chromatogr A 1014:71
Zhou Y, Xu G, Choi FF, Ding LS, Han QB, Song JZ, Qiao CF, Zhao QS, Xu HX (2009) J Chromatogr A 1216:4847–4858
Cargile BJ, Bundy JL, Stephenson JL Jr (2004) J Proteome Res 3:1082–1085
Abdenur JE, Chamoles NA, Guinle AE, Schenone AB, Fuertes AN (1998) J Inherited Metab Dis 21:624–630
Walker GS, O’Connell TN (2008) Expert Opin Drug Metab Toxicol 4:1295–1305
Geier FM, Want EJ, Leroi AM, Bundy JG (2011) Anal Chem 83:3730–3736
Jia CQ, Shi HM, Jin W, Zhang K, Jiang Y, Zhao MB, Tu PF (2009) Drug Metab Dispos 37:431–438
Gillotin F, Chiap P, Frédérich M, Van Heugen JC, Francotte P, Lebrun P, Pirotte B, de Tullio P (2010) Drug Metab Dispos 38:232–240
Fredenhagen A, Kittelmann M, Oberer L, Kuhn A, Kühnöl J, Délémonté T, Aichholz R, Wang P, Atadja P, Shultz MD (2012) Drug Metab Dispos 40:1041–1050
Fabro S, Smith RL, Williams RT (1967) Nature 215:296
Totta P, Acconcia F, Virgili F, Cassidy A, Weinberg PD, Rimbach G, Marino M (2005) J Nutr 135:2687–2693
van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone MJ (2002) J Med Chem 45:3709–3720
Matsukawa K, Ogata M, Hikage T, Minami H, Shimotai Y, Saitoh Y, Yamashita T, Ouchi A, Tsutsumi R, Fujioka T, Tsutsumi K (2006) Biosci Biotechnol Biochem 70:1046–1048
Chen L, Liu JC, Zhang XN, Guo YY, Xu ZH, Cao W, Sun XL, Sun WJ, Zhao MG (2008) Neuropharmacology 54:1175–1181
Oztürk N, Korkmaz S, Oztürk Y, Başer KH (2006) Planta Med 72:289–294
Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX (2010) J Chem Biol Interact 188:127–133
Wang AY, Lian LH, Jiang YZ, Wu YL, Nan JX (2010) World J Gastroenterol 16:384–391
Lian LH, Wu YL, Song SZ, Wan Y, Xie WX, Li X, Bai T, Ouyang BQ, Nan JX (2010) J Agric Food Chem 58:13013–13019
Chineses Pharmacopoeia Commission. (2010) Pharmacopoeia of the People’s Republic of China. Beijing
Wang D, Xu M, Zhu HT, Chen KK, Zhang YJ, Yang CR (2007) Bioorg Med Chem Lett 17:3195–3197
Popov SS, Marekov NL, Do TN (1988) J Nat Prod 51:765–768
el-Sedawy AI, Hattori M, Kobashi K, Namba T (1989) Chem Pharm Bull 37:2435–2437
Zeng WL, Han H, Tao YY, Yang L, Wang ZT, Chen KX (2013) Biomed Chromatogr 27:1129–1136
Wang CH, Cheng XM, Bligh SW, White KN, Branford-White CJ, Wang ZT (2007) J Pharm Biomed Anal 44:1113–1117
Cogne AL, Queiroz EF, Marston A, Wolfender JL, Mavi S, Hostettmann K (2005) Phytochem Anal 16:429–439
Zhang L, Yu Q, He J, Zha X (2004) Mol Cell Biochem 262:25–33
McLafferty FW (1959) Anal Chem 31:82–87
Baghdikian B, Guiraud-Dauriac H, Ollivier E, N’Guyen A, Dumenil G, Balansard G (1999) Planta Med 65:164–166
El-Sedawy AI, Shu YZ, Hattori M, Kobashi K, Namba T (1989) Planta Med 55:147–150
Han H, Yang L, Xu Y, Ding Y, Bligh SW, Zhang T, Wang ZT (2011) Rapid Commun Mass Spectrom 25:3339–3350
Inouye H, Ueda S, Takeda Y (1968) Tetrahedron Lett 30:3453–3458
Dröge W (2002) Physiol Rev 82:47–95
Wang T, Weinman SA (2006) J Gastroenterol Hepatol 21:S34–S37
Chou CC, Pan SL, Teng CM, Guh JH (2003) Eur J Pharm Sci 19:403–412
Stephens PJ, Devlin FJ, Gasparrini F, Ciogli A, Spinelli D, Cosimelli B (2007) J Org Chem 72:4707–4715
Berova N, Di Bari L, Pescitelli G (2007) Chem Soc Rev 36:914–931
Yang XW, Ding Y, Li XC, Ferreira D, Shen YH, Li SM, Wang N, Zhang WD (2009) Chem Commun 7:3771–3773
Jenner P, Testa B (1973) Drug Metab Rev 2:117–184
Long JP, Luduena FP, Tullar BF, Lands AM (1956) J Pharmacol Exp Ther 117:29–37
Hutt AJ (2007) Drug Metab Drug Interact 22:79–112
Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C (2002) Drug Metab Dispos 30:1288–1295
Acknowledgments
The financial support of the National Natural Science Foundation of China (81073027), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1071), and the Shanghai Science and Technology Development Foundation (12QH1402200) are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 4102 kb)
Rights and permissions
About this article
Cite this article
Han, H., Xiong, AZ., He, CY. et al. Combination of UHPLC/Q-TOF-MS, NMR spectroscopy, and ECD calculation for screening and identification of reactive metabolites of gentiopicroside in humans. Anal Bioanal Chem 406, 1781–1793 (2014). https://doi.org/10.1007/s00216-013-7572-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-013-7572-z